Anxiety and depression among medical doctors in Catalonia, Italy, and the UK during the COVID-19 pandemic. by Quintana-Domeque, Climent et al.
RESEARCH ARTICLE
Anxiety and depression among medical
doctors in Catalonia, Italy, and the UK during
the COVID-19 pandemic
Climent Quintana-DomequeID
1,2,3,4*, Ines Lee5, Anwen Zhang6, Eugenio Proto4,6,7,8,
Michele Battisti4,6,8,9, Antonia HoID
10
1 Department of Economics, Business School, University of Exeter, Exeter, United Kingdom, 2 GLO, Essen,
Germany, 3 Department of Economics, HCEO, University of Chicago, Chicago, IL, United States of America,
4 IZA, Bonn, Germany, 5 Faculty of Economics, University of Cambridge, Cambridge, United Kingdom,
6 Department of Economics, Adam Smith Business School, University of Glasgow, Glasgow, United
Kingdom, 7 CEPR, London, United Kingdom, 8 CESifo, Munich, Germany, 9 CReAM, London, United
Kingdom, 10 MRC-University of Glasgow Centre for Virus Research, Glasgow, United Kingdom
* c.quintana-domeque@exeter.ac.uk
Abstract
Healthcare workers have had the longest and most direct exposure to COVID-19 and con-
sequently may suffer from poor mental health. We conducted one of the first repeated multi-
country analysis of the mental wellbeing of medical doctors (n = 5,275) at two timepoints
during the COVID-19 pandemic (June 2020 and November/December 2020) to understand
the prevalence of anxiety and depression, as well as associated risk factors. Rates of anxi-
ety and depression were highest in Italy (24.6% and 20.1%, June 2020), second highest in
Catalonia (15.9% and 17.4%, June 2020), and lowest in the UK (11.7% and 13.7%, June
2020). Across all countries, higher risk of anxiety and depression symptoms were found
among women, individuals below 60 years old, those feeling vulnerable/exposed at work,
and those reporting normal/below-normal health. We did not find systematic differences in
mental health measures between the two rounds of data collection, hence we cannot dis-
card that the mental health repercussions of the pandemic are persistent.
Introduction
The coronavirus disease 2019 (COVID-19) pandemic has affected many individuals both
directly and indirectly, disrupting routines and introducing new stressors [1]. Recent studies
have shown that the pandemic has unequal effects on the psychological wellbeing of individu-
als, with women, younger individuals, and ethnic minorities being disproportionately affected
[2, 3]. Effects also vary by occupational groups as certain jobs expose workers more directly to
the disease [4–6]. The mental wellbeing of healthcare workers has been particularly affected by
the pandemic [7–10].
Healthcare workers have been directly involved in the management of COVID-19 patients
since the beginning of the pandemic. Drawing on the experiences of healthcare workers during
the 2003 SARS outbreak, various mental health risk factors have been identified: lack of
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personal protective equipment (PPE), overwhelming workload, lack of institutional support,
and fear of infecting others [11–14]. Several studies have documented high rates of anxiety and
depression symptoms among healthcare workers during the COVID-19 pandemic, with vari-
ous risk factors such as fear of infection being identified as important [7, 8]. Most of the studies
are from China [8, 9, 15] and a handful document similar patterns in other regions [10].
Various local and national mental health institutions around the world have begun to offer
psychological assistance to those in need, with some services targeted specifically at healthcare
workers [16–19]. Poor mental health among healthcare workers may have downstream effects
on patients via worsened attention span, cognitive function, and clinical decision making [10].
Providing such assistance to healthcare workers requires understanding the state of their men-
tal wellbeing, factors associated with mental health symptoms, and how these outcomes and
factors vary across time and countries.
The aim of this study is to estimate the prevalence of anxiety and depression symptoms
among medical doctors in multiple countries during the pandemic, as well as the risk factors
associated with those symptoms. Drawing on the existing literature [7–9, 20–23], we hypothe-
size that certain demographic characteristics (e.g. sex and age), workplace safety (e.g. lack of
necessary PPE), COVID-19 experience (e.g. directly treating COVID-19 patients), and health
and lifestyle factors (e.g. long working hours) are associated with anxiety and depression.
This study provides one of the first repeated cross-country analyses of mental wellbeing
among healthcare workers during the COVID-19 pandemic. Our sample comprises medical
doctors working in Catalonia, Italy, or the UK in June (first data collection round) and
November/December 2020 (second data collection round). Both the monthly COVID-19
prevalence and mortality rates increased between the two data collection rounds (S1 Table in
S1 Appendix). COVID-19 cases per 100,000 increased from 33.3 (June 2020) to 809.6 (Novem-
ber 2020) in Catalonia, from 12.5 (June 2020) to 836.3 (December 2020) in Italy, and from 55.6
(June 2020) to 927.1 (November 2020) in the UK. Between the two rounds of data collection,
COVID-19 deaths per 100,000 increased from 2.4 to 22.2 in Catalonia, from 2.2 to 30.7 in
Italy, and from 4.4 to 17.8 in the UK.
In contrast to existing studies, our data allow us to quantify the prevalence of and risk fac-
tors associated with anxiety and depression symptoms across countries and to examine these
outcomes at two timepoints. While previous studies have investigated heterogeneous samples
of healthcare workers, our analysis focuses on medical doctors. The results of our study can
inform how to protect and promote the mental wellbeing of medical doctors in current and
future pandemics.
Methods
We conducted an anonymous survey, The Healthcare Workers Survey, approved by the Uni-
versity of Exeter Business School Research Ethics Committee (eUEBS003024). Informed writ-
ten consent was provided by all survey participants prior to their participation. Participants
understood that they may withdraw from the study at any time. We followed the reporting
guidelines of the American Association for Public Opinion Research (S2 Table in S1
Appendix).
The study is a repeated cross-sectional survey among members of 6 medical organizations:
the COMB (Barcelona Medical Council) and the COMG (Girona Medical Council) in Catalo-
nia (Spain), Anaao-Assomed (Union of physicians and healthcare executives) and the FIMMG
(Union of general practitioners) in Italy, as well as the RCPSG (Royal College of Physicians
and Surgeons of Glasgow) and the RCSEd (Royal College of Surgeons of Edinburgh) in the
UK.
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Due to different membership rules, members of the Catalan and Italian institutions work in
Catalonia and Italy, while the Scottish institutions have members who work in different parts
of the UK (S3 Table in S1 Appendix). The survey was designed in Qualtrics and was distrib-
uted via email by the corresponding institutions.
Participants
Our data collection relied on the mailing lists of the respective medical organizations. The
COMB invited 5,062 members in June and November 2020 (19.9%), focusing on those with
medical license numbers ending in 1 or 2 (S1 Fig in S1 Appendix). This random sampling was
chosen to avoid over-burdening members, given that other surveys were taking place at the
same time. The other institutions sent invitations to all members. The COMG invited 3,120
members in June and November 2020. Similarly, the Anaao-Assomed invited 23,379 mem-
bers, and the FIMMG invited 17,686 members in June and December 2020. The RCPSG
invited 3,990 members in June 2020 and 4,300 members in November 2020 (S2 Fig in S1
Appendix). The RCSEd invited 4,992 members in June 2020 and 4,912 members in November
2020 (S3 Fig in S1 Appendix).
We included in our final sample those respondents that satisfy the following criteria (see S4
Table in S1 Appendix): (a) for whom we had information on sex, age, household composition,
occupation, and specialty; (b) were working in the same region/country as the medical institu-
tion that they are a member of; (c) were medical professionals; (d) had typical work arrange-
ments when surveyed (not retired, on leave, or shielding). In the first round, out of
approximately 55,000 invited members, the final sample size was 3,025 (5.5%). In the second
round, the final sample size was 2,250 (4.1%). The total number of respondents by region/
country was: 1,849 in Catalonia (n = 876 in round 1, n = 973 in round 2); 2,574 in Italy
(n = 1,637 in round 1, n = 937 in round 2); 852 in the UK (n = 512 in round 1, n = 340 in
round 2). (S5 Table in S1 Appendix) documents the response rates across institutions.
Due to regional/country differences, including language differences (Catalan, English, Ital-
ian), the medical doctors at each institution have different occupation titles. For example, in
the UK the occupational categories were: Consultant, Specialty Doctor and Associate Specialist
(SAS), Specialty registrar, Junior doctor core training, Junior doctor foundation year, General
practitioner, General practitioner trainee. In our statistical analysis, we accounted for both
country and institutional differences in occupational titles.
Outcomes and covariates
The outcomes of the study are anxiety and depression symptoms. Anxiety is measured with
the Generalized Anxiety Disorder (GAD-7) questionnaire, a seven-item self-report anxiety
questionnaire designed to assess health status during the previous two weeks [24, 25]. It has
been validated as an anxiety screening tool and severity measure in different populations [24,
26–28]. GAD-7 scores range from 0 to 21. When used as a binary anxiety indicator, a score of
10 is the recommended threshold for referral for further evaluation [24, 29]. Using this thresh-
old, the GAD-7 has sensitivity of 89% and specificity of 82% for generalized anxiety disorder
[24, 29].
Depression is measured with the depression module of the Patient Health Questionnaire
(PHQ-9), which focuses on the nine diagnostic criteria for DSM-IV depressive disorders [30].
It is a useful tool to assist clinicians in diagnosing depression and a reliable and valid measure
of depression severity [30, 31]. It has been validated in a variety of populations [25, 32, 33].
PHQ-9 scores range from 0 to 27. When used as a binary depression indicator, 10 is the
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recommended cut-off point. Using this threshold, the PHQ-9 has sensitivity and specificity of
88% for major depression [30, 32].
The following covariates were included in our analysis: demographic characteristics (sex,
age, household composition), survey round (June vs. November/December 2020), perceptions
about workplace safety (availability of PPE, reported feelings of vulnerability and exposure,
perceived workplace concerns about workers safety), COVID-19 exposure (symptoms, directly
treating COVID-19 patients, helping with COVID-19 tasks, healthcare worker deaths due to
COVID-19 in the workplace), and health and lifestyle factors (self-reported health status,
underlying health condition, working over 40 hours in the previous week, smoking behavior,
whether the respondent had a flu vaccine this season). We created a binary variable “normal/
below-normal health” that equals 1 if the respondent reported 3 or below on the 1–5 Likert
scale for health status, where higher values correspond to better health, and zero otherwise. (S6
Table in S1 Appendix) describes all the variables. The replication data and code are available in
S1 File.
Statistical analysis
First, we described the demographic characteristics of our respondents. Second, we calculated
the prevalence of anxiety and depression symptoms by country over time. Third, we calculated
the prevalence of anxiety and depression by sex and age in each country. Fourth, we estimated
the perceptions of workplace safety and exposure to COVID-19 by country over time. Finally,
we used multivariable logistic regression to estimate odds ratios (ORs) for the association
between anxiety (and depression) symptoms and the aforementioned covariates, controlling
for occupational indicators and institutional indicators (i.e. COMB, COMG, Anaao-Assomed,
FIMMG, RCPSG, RCSEd). The inclusion of both country-specific occupational indicators and
institutional indicators allows us to account for region/country and institutional differences in
occupational titles. Stata statistical software version 16.1 (StataCorp) was used for statistical
analyses. P-values were 2-sided and statistical significance was set at p<0.05. Data were ana-
lyzed from March 4 to June 4, 2021.
Results
Table 1 presents demographic characteristics of the participants by region/country and round.
The percentage of respondents who were women and men differed across countries. In Italy, it
was similar (50%). However, over 64% of respondents were women in Catalonia and below
35% were women in the UK. The age distribution of respondents also varied by country. The
percentage of respondents younger than 60 years was over 83% in the UK, below 73% in Cata-
lonia and below 60% in Italy.
Table 1. Demographic characteristics of respondents.
Catalonia Italy UK
Round 1 Round 2 Round 1 Round 2 Round 1 Round 2
Men 311 (35.50) 326 (33.50) 846 (51.68) 468 (49.95) 358 (69.92) 358 (65.00)
Women 565 (64.50) 647 (66.50) 791 (48.32) 469 (50.05) 154 (30.08) 154 (35.00)
Age < 60 633 (72.26) 702 (72.15) 907 (55.41) 562 (59.98) 427 (83.40) 427 (84.12)
Age� 60 243 (27.74) 271 (27.85) 730 (44.59) 375 (40.02) 85 (16.60) 85 (15.88)
Notes: Percentages reported in parentheses. Round 1 corresponds to June 2020 for all countries; Round 2 corresponds to November 2020 for Catalonia and the UK and
December 2020 for Italy.
https://doi.org/10.1371/journal.pone.0259213.t001
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Fig 1 documents the prevalence of moderate/above-moderate symptoms of anxiety (GAD-
7�10) and depression (PHQ-9�10) by country over time. In June 2020 the prevalence of
moderate anxiety (panel A) was higher in Italy (24.6% [95% CI, 22.5%-26.7%]) than in Catalo-
nia (15.9% [95% CI, 13.4%-18.3%]) and the UK (11.7% [95% CI, 8.9%-14.5%]). A similar con-
clusion emerges when looking at round 2. In June 2020, the prevalence of moderate/above-
Fig 1. Prevalence of anxiety and depression symptoms by country over time. Grey bars correspond to Nov 2020 for
Catalonia and UK, and to Dec 2020 for Italy. Anxiety symptoms = 1 if GAD-7� 10 and depression symptoms = 1 if
PHQ-9� 10. 95% confidence intervals.
https://doi.org/10.1371/journal.pone.0259213.g001
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moderate depression (panel B) was highest in Italy (20.1% [95% CI, 18.2%-22.0%]), second
highest in Catalonia (17.4% [95% CI, 14.8%-19.9%]), and lowest in the UK (13.7% [95% CI,
10.7%-16.7%]). In round 2, the prevalence of moderate/above-moderate depression was higher
in Italy (21.7% [95% CI, 19.0%-24.3%]) than in Catalonia (15.9% [95% CI, 13.6%-18.2%]).
There were no differences in the prevalence of anxiety and depression across the two rounds
of the survey in any of the countries/regions, suggesting that the mental health repercussions
of the pandemic might be persistent. (S4 Fig in S1 Appendix) presents a further breakdown of
the prevalence of symptoms depending on intensity.
Fig 2 investigates the differences in the prevalence of moderate/above-moderate symptoms
of anxiety and depression by sex and age across countries. Panel A shows that the prevalence
of moderate/above-moderate symptoms of anxiety was higher among women than among
men in Catalonia (women: 17.3%, [95% CI, 15.2%-19.5%], men: 10.2%, [95% CI, 7.9%-12.6%])
and Italy (women: 32.4%, [95% CI, 29.8%-35.0%], men: 19.7%, [95% CI, 17.6%-21.9%]). Panel
B shows that the prevalence of moderate/above-moderate symptoms of depression was higher
among women than among men in Catalonia (women: 19.0%, [95% CI, 16.8%-21.2%], men:
12.1%, [95% CI, 9.6%-14.6%]) and Italy (women: 26.3%, [95% CI, 23.8%-28.7%], men: 15.3%,
[95% CI, 13.4%-17.3%]). Panel C shows that the prevalence of moderate/above-moderate
symptoms of anxiety was higher among younger (<60 y) than older (�60 y) respondents in all
Fig 2. Prevalence of anxiety and depression by sex and age across countries. Grey bars are for women (panel A and B) and over 60 (panels C and
B). Anxiety symptoms = 1 if GAD-7� 10 and depression symptoms = 1 if PHQ-9� 10. 95% confidence intervals.
https://doi.org/10.1371/journal.pone.0259213.g002
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three countries: Catalonia (<60 y: 17.0%, [95% CI, 15.0%-19.0%],�60 y: 9.3%, [95% CI, 6.8%-
11.9%]), Italy (<60 y: 29.3%, [95% CI, 26.9%-31.6%],�60 y: 21.5%, [95% CI, 19.0%-23.9%]),
and the UK (<60 y: 15.6%, [95% CI, 12.9%-18.2%],�60 y: 7.2%, [95% CI, 2.8%-11.5%]). Simi-
larly, Panel D shows that the prevalence of moderate/above-moderate symptoms of depression
was higher among younger (<60 y) than older (�60 y) respondents across all countries.
Fig 3 describes perceptions of workplace safety and exposure to COVID-19. Around half of
Italian respondents did not agree with the statement “my workplace is providing me with the
necessary PPE” in June 2020 (50.1%, [95% CI, 47.6%-52.6%] (panel A). This decreased to
30.1% [95% CI, 27.1%-33.1%] in December 2020. In Catalonia, the percentage was 25.8% [95%
CI, 22.8%-28.7%] in June 2020, and decreased to 15.4% [95% CI, 13.0%-17.7%] in November
2020. In the UK, 16.1% [95% CI, 12.9%-19.4%] of respondents disagreed with this statement
in June 2020 and only 1 in 10 respondents disagreed with this statement in November 2020
(10.1%, [95% CI, 6.8%-13.3%]). Panel B shows that the percentage of respondents who agreed
with the statement “I feel vulnerable and exposed at work” remained constant between rounds;
including 1 in 5 respondents in Catalonia and the UK, and nearly 1 in 2 in Italy. It is notable
that the country with the lowest rates of perceived workplace safety (Italy) also has the highest
rates of anxiety symptoms.
Fig 3. Perceptions of safety and COVID-19 exposure in the workplace. Panel A: Percentage of respondents who did not agree with the statement
“my workplace is providing me with the necessary Protective Personal Equipment”. Panel B: Percentage of respondents who agreed/strongly agreed
with the statement “I feel vulnerable and exposed at work”. Panel C: Percentage of respondents who “directly looked after COVID-19 patients last
week”. Panel D: Percentage of respondents who were aware of “at least one COVID-19 death among healthcare workers in their workplace”.
https://doi.org/10.1371/journal.pone.0259213.g003
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Panel C illustrates that the percentage of respondents that have “directly looked after
COVID-19 patients last week” increased between June and November 2020 in Catalonia
(29.6%, [95% CI, 26.6%-32.7%] to 43.4%, [95% CI, 40.4%-46.8%]) and between June and
November 2020 in Italy (25.0% [95% CI, 22.9%-27.1%] to 58.0% [95% CI, 54.8%-61.2%]). In
contrast, the percentage remained similar between the two rounds in the UK (30.2% [95% CI,
26.1%-34.2%] vs. 34.3% [95% CI, 29.2%-39.4%]). Lastly, Panel D shows that 1 in 5 respondents
in Catalonia were aware of at least one COVID-19 death among healthcare workers in their
workplace in June 2020 and November 2020. In Italy, this ratio increased from 1 in 3 in June
2020 (31.4%, [95% CI, 29.1%-33.7%]) to 2 in 5 in December 2020 (40.6%, [95% CI, 37.4%-
43.8%]). In the UK, it remained constant at about 1 in 3 respondents. The increase across sur-
vey rounds in the percentage of medical doctors directly treating COVID-19 patients in the
last week in Catalonia and Italy matches the evolution of the pandemic reported in S1 Table in
S1 Appendix.
After pooling together all countries and the two rounds of data, Fig 4 displays the odds-
ratios (ORs) of various risk factors estimated using a multivariable logit specification with
binary anxiety and depression indicators as the dependent variables. In this figure, we focus on
factors that related literature has demonstrated to be correlated with mental health [7–9, 20–
Fig 4. Risk factors of anxiety and depression symptoms, odds ratios and 95% CI. The figure displays the odds ratio of each variable (and its
corresponding 95% CI) from a multivariable logistic regression pooling across all countries and timepoints. The dependent variables are binary
indicators for anxiety (circle markers) or depression (diamond markers).
https://doi.org/10.1371/journal.pone.0259213.g004
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23]. In addition to the variables listed in the figure, the regression also controls for indicators
for smoking, a flu vaccine this season, living with a child under 5, living with someone over 60,
occupational indicators, and institutional indicators. (S7 Table in S1 Appendix) reports full
regression tables for the pooled sample and separate countries.
Controlling for health behaviors, household composition, occupational indicators and
institutional indicators, women, younger individuals (< 60 years), those who feel vulnerable
and exposed at work, those who think that their workplace has shown little concern for their
safety, those who directly looked after COVID-19 patients last week, those with normal/below-
normal health status (i.e. with a self-reported health status of 3 or below on a 1–5 Likert scale,
where higher values correspond to better health), and those who worked over 40 hours last
week had higher odds of anxiety and/or depression symptoms.
Women had higher odds of anxiety (OR = 1.77 [95% CI, 1.50–2.07]) and depression
(OR = 1.76 [95% CI, 1.49–2.09]) compared to men. Compared with individuals above 60
years, younger individuals had higher odds of anxiety (OR = 1.49 [95% CI, 1.22–1.82]) and
depression (OR = 1.58 [95% CI, 1.28–1.96]). A reported lack of necessary PPE in the workplace
was associated with higher odds of anxiety (OR = 1.39 [95% CI, 1.15–1.68]) and depression
(OR = 1.27 [95% CI, 1.04–1.56]). Respondents who felt vulnerable or exposed in their work-
place had greater odds of anxiety and depression symptoms compared with respondents who
did not feel vulnerable or exposed (OR = 1.68 [95% CI, 1.41–2.00]; OR = 1.72 [95% CI, 1.43–
2.06]). Compared with respondents who reported above-normal health (i.e. above 3 on a 1–5
scale), individuals who reported a normal/below-normal health status (i.e. 3 or below on a 1–5
scale), had higher odds of anxiety (OR = 2.58 [95% CI, 2.13–3.13]) and depression (OR = 3.35
[95% CI, 2.76–4.06]). Compared with individuals who worked below 40 hours, those who
worked 40 hours or more last week had higher odds of anxiety (OR = 1.44 [95% CI, 1.21–
1.70]) and depression (OR = 1.27 [95% CI, 1.07–1.52]). (S6 Table in S1 Appendix) shows that
these patterns hold for specific countries too.
Discussion
This is one of the few studies to provide a multi-country analysis of the mental wellbeing of
medical doctors at two timepoints during the COVID-19 pandemic. Among respondents
from Catalonia, Italy and the UK, the prevalence of anxiety and depression was highest among
medical doctors in Italy, with 1 in 4 suffering from anxiety symptoms in June and December
2020 and 1 in 5 suffering from depression symptoms over the same period. Within each coun-
try, no difference in the prevalence of anxiety and depression were reported between the first
and second rounds of the survey. Hence, we cannot discard that the mental health repercus-
sions of the pandemic are persistent.
In Catalonia, Italy, and the UK, higher risk of anxiety and depression symptoms was found
among women, individuals below 60 years old, those feeling vulnerable/exposed at work, and
those reporting normal/below-normal health. These associated risk factors provide a few pos-
sible reasons for the variation in the prevalence of anxiety and depression across countries. For
example, the percentage of respondents who reported a lack of necessary PPE and reported
feeling vulnerable and exposed at work was highest in Italy, where rates of anxiety and depres-
sion were also highest.
Our findings are consistent with other studies that have examined the rates of anxiety and
depression among healthcare workers during the pandemic. In Spain, Alonso et al. [20] find
that among 9,138 respondents (26.4% physicians, 77.3% women) working in 6 places (includ-
ing Catalonia) during May and September 2020, the prevalence of depression (PHQ-8�10)
and anxiety (GAD-7�10) was 22.4% (vs. 16.5% in our Catalan sample) and 17.0% (vs. 14.9%
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in our Catalan sample). In Italy, Rossi et al. [21] find that among 1,379 respondents (31.4%
physicians, 77.2% women) surveyed in March 2020, the prevalence of depression (PHQ-
9�15) and anxiety (GAD-7�15) was 24.7% (vs. 6.6% in our Italian sample) and 19.8% (vs.
9.5% in our Italian sample). Conti et al. [34, 35] find similar magnitudes. In the UK, Greenberg
et al. [36] find that among 709 staff (41% doctors) working in English hospitals in summer
2020, the prevalence of moderate (PHQ-9�10) and severe (PHQ-9�20) depression was 37%
and 6%, respectively (26% and 6% among doctors, vs. 16.2% and 2.7% in our UK sample), and
that the prevalence of moderate (GAD-7�10) and severe (GAD-7�15) anxiety was 27% and
11%, respectively (20% and 8% among doctors, vs. 14.2% and 5.9% in our UK sample). Greene
et al. [37] find comparable rates.
Our findings are also consistent with studies investigating risk factors of mental health
among healthcare workers. In a review of 24 studies, De Kock et al. [7] show that risk factors
included underlying health, being female, concerns about workplace safety [22, 23], contact
with COVID-19 [8, 38, 39], and concerns about the wellbeing of others [22]. In Spain, Alonso
et al. [20] find that healthcare professionals frequently exposed to COVID-19 patients were sta-
tistically significantly more likely to experience mental health disorders (OR = 3.98, 95% CI:
3.27–4.85). In Italy, Rossi et al. [21] find that being female was associated with higher GAD-7
(OR = 2.18, 95% CI: 1.49–3.19) and PHQ-9 scores (OR = 2.03, 95% CI: 1.44–2.87). In the UK,
Siddiqui et al. [40] find that among 558 healthcare professionals (51% doctors, 31% nurses),
concerns about exposure to COVID-19 and the lack of PPE were important causes of anxiety.
Contributions
Our study contributes to monitoring the mental wellbeing of medical doctors during the
COVID-19 pandemic. Including multiple countries and timepoints allow comparison between
different settings, and improves our understanding about how medical doctors have been
affected at different points during the pandemic. The similar patterns across countries suggest
that our findings may be generalizable to other European settings. Rather than relying on
online convenience samples, our sampling technique relies on the institutional mailing lists of
medical organizations. In comparison to previous studies, we focus on medical doctors rather
than a broader group of healthcare workers.
Limitations
This study has several limitations. First, when comparing two cross-sectional surveys for each
country, we were not necessarily comparing the same individuals. Differences in prevalence of
mental health symptoms could be driven by changes in sample composition across waves.
Relatedly, the survey did not take place at the same point during an epidemic wave in data col-
lection rounds 1 and 2.
Second, participants in our survey are not necessarily representative of the underlying pop-
ulations of medical doctors and may be self-selected since they voluntarily take part in the sur-
vey. Reporting bias is likely. If individuals with symptoms were more likely to respond (e.g. to
express grievances), then our estimates may be higher than the population average. Con-
versely, if individuals with above-average symptoms were less likely to respond (e.g. due to
time constraints), then our estimates may be below the population average.
Third, anxiety and depression symptoms may not be comparable across countries due to
different reporting norms in the GAD-7 and PHQ-9 questionnaires. Reassuringly, our pooled
multivariable logistic regressions produce similar results even when controlling for occupation
and institution indicators.
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Finally, our measures of anxiety and depression are not based on an objective diagnosis
made by a clinician.
Conclusion
The COVID-19 pandemic has been classified as a traumatic event [1]. Healthcare workers
have arguably had the most direct and longest exposure to this disease. Our study identified a
high prevalence of anxiety and depression among medical doctors in both the first and second
waves of the pandemic, contributing to a wider literature examining the effects of traumatic
events on mental wellbeing [41], especially on those who are most exposed because of the
demands of their occupation. The results of this study suggest that institutional support for
healthcare workers, and in particular medical workers, is important in protecting and promot-
ing their mental health in the current and in future pandemics.
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